Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. This Business Profile tracks the Brand Authority Index and supporting AI visibility evidence. Last analyzed April 10, 2026.
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. They specialize in multi-cancer early detection (MCED) through liquid biopsy technology, specifically using high-intensity sequencing and data science to identify tumor-derived cell-free DNA in the blood.
Optimly has not yet published enough evidence to assess how often AI assistants recommend GRAIL.
Optimly has not yet published a supported competitor set for GRAIL.
Official website: https://grail.com/
Last analyzed: April 10, 2026
This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.
If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile